Synbio Tech Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	1,001	989.48	823.3	739.33
Revenue Growth (YoY)	2.61%	20.18%	11.36%	-
Cost of Revenue	459.95	448.64	404.56	378
Gross Profit	540.63	540.84	418.75	361.33
Selling, General & Admin	238.54	222.88	275.79	259.49
Research & Development	114.04	108.57	-	-
Operating Expenses	352.72	331.45	275.79	259.82
Operating Income	187.91	209.4	142.96	101.5
Interest Expense	-7.02	-3.71	-6.6	-7.69
Interest & Investment Income	10.06	9.27	7.34	6.54
Currency Exchange Gain (Loss)	-	-	-3.16	10.08
Other Non Operating Income (Expenses)	2.21	21.64	6.58	5.27
EBT Excluding Unusual Items	193.16	236.59	147.12	115.7
Gain (Loss) on Sale of Assets	-	-	-0.06	-
Pretax Income	193.16	236.59	147.07	115.7
Income Tax Expense	37.56	66.47	33.8	23.18
Net Income	155.61	170.13	113.27	92.52
Net Income to Common	155.61	170.13	113.27	92.52
Net Income Growth	-13.48%	50.19%	22.43%	-
Shares Outstanding (Basic)	32	31	31	31
Shares Outstanding (Diluted)	33	32	31	31
Shares Change (YoY)	3.83%	0.02%	0.02%	-
EPS (Basic)	4.79	5.43	3.61	2.96
EPS (Diluted)	4.77	5.40	3.60	2.94
EPS Growth	-16.57%	50.08%	22.33%	-
Free Cash Flow	-361.68	-40.62	-113.36	-29.54
Free Cash Flow Per Share	-11.09	-1.29	-3.60	-0.94
Dividend Per Share	-	3.500	1.471	1.961
Dividend Growth	-	138.00%	-25.00%	-
Gross Margin	54.03%	54.66%	50.86%	48.87%
Operating Margin	18.78%	21.16%	17.36%	13.73%
Profit Margin	15.55%	17.19%	13.76%	12.51%
Free Cash Flow Margin	-36.15%	-4.11%	-13.77%	-4.00%
EBITDA	261.79	285.44	215.04	173.4
EBITDA Margin	26.16%	28.85%	26.12%	23.45%
D&A For EBITDA	73.88	76.04	72.08	71.9
EBIT	187.91	209.4	142.96	101.5
EBIT Margin	18.78%	21.16%	17.36%	13.73%
Effective Tax Rate	19.44%	28.09%	22.98%	20.03%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.